What laboratory test should be performed to diagnose pertussis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for Pertussis

For definitive diagnosis of pertussis, order a nasopharyngeal aspirate or Dacron swab for culture, as bacterial isolation is the only certain way to confirm the diagnosis. 1

Diagnostic Testing Algorithm

Primary Diagnostic Test: Culture

  • Nasopharyngeal culture remains the gold standard for confirming Bordetella pertussis infection, with 100% specificity and approximately 64% sensitivity when performed optimally 1, 2
  • Collect specimen via nasopharyngeal aspirate or polymer (Dacron) swab 1
  • Critical timing consideration: Culture is most sensitive when performed during the first 2 weeks of cough 2
  • Important caveat: Culture requires enriched media and sensitivity can be as low as 25-50% in routine practice 1

Alternative/Adjunctive Tests

Polymerase Chain Reaction (PCR)

  • PCR demonstrates 80-100% sensitivity and 88-100% specificity, making it more sensitive than culture 1, 2
  • PCR is rapid and highly specific for Bordetella species 1
  • Major limitation: The ACCP guidelines note that PCR is not recommended for routine clinical testing because no universally accepted, validated technique exists (Grade I evidence) 1
  • However, more recent evidence from 2021 confirms PCR has replaced culture as the preferred confirmatory test in clinical practice 3
  • Optimal timing: Most sensitive during the first 2 weeks of cough 2

Serology (Anti-Pertussis Toxin IgG)

  • Order paired acute and convalescent sera to demonstrate a fourfold increase in IgG or IgA antibodies to pertussis toxin (PT) or filamentous hemagglutinin (FHA) 1
  • First serum sample should be collected within 2 weeks of cough onset; second sample 3-4 weeks later 1
  • Reported specificity of 99% and sensitivity of 63% for documenting community outbreaks 1
  • Critical limitation: No serologic method has been validated and approved for diagnostic use in the United States 1
  • Optimal timing: Most sensitive after the second week of cough, when culture and PCR sensitivity decline 2
  • Single high-titer specimens are highly suggestive but not confirmatory 1

Practical Clinical Approach

When to Test

Test patients with cough lasting >2 weeks accompanied by:

  • Paroxysmal coughing 1
  • Post-tussive vomiting 1
  • Inspiratory whooping sound 1

Specimen Collection Timing Strategy

  • Week 1-2 of cough: Order culture or PCR (highest yield period) 2
  • Week 3+ of cough: Consider serology as culture/PCR sensitivity declines 2
  • For patients presenting late (>2 weeks), paired sera may provide retrospective diagnosis but has limited clinical utility since patients often delay seeking care 1

Common Pitfalls to Avoid

  1. Delaying treatment while awaiting confirmation: Begin antibiotic therapy as soon as pertussis is suspected; do not wait for laboratory confirmation 1

  2. Missing the optimal testing window: Culture and PCR sensitivity drops significantly after 2 weeks of symptoms 2

  3. Relying on single serology samples: Paired sera are necessary as non-rising titers may represent past infection or previous immunization 1

  4. Expecting PCR standardization: Despite widespread use, PCR assays remain non-standardized across laboratories 1

  5. Using serology in infants: Serology is not useful in young infants 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.